Trials / Unknown
UnknownNCT03614143
Biomarker Study for Prediction of aGVHD
Biomarker Identification for aGVHD After Allogeneic Stem Cell Transplantation: a Multiple Center Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective study in patients receiving allogeneic stem cell transplantation. The blood samples on Day-14, -7, 0 and every 7 days until D100 were collected together with clinical data. In the final analysis, cytokines and biomarkers analysis will be carried out and compared between patients in No aGVHD and grade II-IV aGVHD.
Detailed description
This is a prospective study, observation study in patients receiving allogeneic stem cell transplantation in 4 BMT centers in Shanghai. The blood samples (on Day-14, -7, 0 and every 7 days until D100) and clinical data will be collected. In the final analysis, a panel of cytokines and biomarkers analysis of serial blood samples will be carried out and compared between patients with no aGVHD and grade II-IV aGVHD.
Conditions
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-12-01
- Completion
- 2020-07-01
- First posted
- 2018-08-03
- Last updated
- 2018-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03614143. Inclusion in this directory is not an endorsement.